https://www.selleckchem.com/pr....oducts/pf-06873600.h
Participants will be at least 23 years old and of any gender. Patient recruitment will start in February 2021 and is expected to be completed by December 2021. Primary outcome measures include fasting plasma glucose, blood pressure, triglycerides, high-density lipoprotein and waist circumference, while secondary feature absolute change in the sum of the individual factors of MetS and change in each individual factor of MetS measured at each study time point. The approval of research ethics committee (REC) regarding the trial protoco
Beğen
Yorum Yap
Paylaş
